Survodutide
GLP-1/Glucagon Agonist
Brand names: Survodutide
Oral
Mechanism of Action
Dual GLP-1 and glucagon receptor agonist that combines appetite suppression with increased energy expenditure.
Indications
Obesity (Phase 3)
MASH/NASH (Phase 3)
Known Side Effects
0 documented side effects by frequency
No structured side effect data available.
Community Discussions
No community discussions found for Survodutide yet.
Compare With
0 available comparisons
No comparisons yet.
Formulations
Dosage Forms
Tablet
Route
Oral